Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VCL-CB01 in HCT Donors and Recipients
NCT00285259Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Jan 2006
- Primary completion
- Nov 2009
- Modality
- Prophylactic Vaccines, DNA Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of ASP0113 in cytomegalovirus infection (CMV), sponsored by Astellas Pharma. Started Jan 2006; status: completed.
02
Drugs
ASP0113
03
Conditions
cytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT00285259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00285259.